Zou Yixuan, Chen Tingtao
Institute of Translational Medicine, National Engineering Research Center for Bioengineering Drugs and Technologies, Nanchang University, Nanchang, Jiangxi 330031, P.R. China.
Exp Ther Med. 2020 Dec;20(6):285. doi: 10.3892/etm.2020.9415. Epub 2020 Oct 29.
Achieving a harmonious gut microbial ecosystem has been hypothesized to be a successful method for alleviating metabolic disorders. The administration of probiotics, such as and , is a known traditional and safe pathway to regulate human commensal microbes. With advancements in genetic sequencing and genetic editing tools, more bacteria are able to function as engineered probiotics with multiple therapeutic properties. As one of the next-generation probiotic candidates, () has been discovered to enhance the gut barrier function and moderate inflammatory responses, exhibit improved effects with pasteurization and display beneficial probiotic effects in individuals with obesity, type 2 diabetes, atherosclerosis and autism-related gastrointestinal disturbances. In view of this knowledge, the present review aimed to summarize the effects of in the treatment of metabolic disorders and to discuss several mature recombination systems for the genetic modification of . From gaining an enhanced understanding of its genetic background, ingested is expected to be used in various applications, including as a diagnostic tool, and in the site-specific delivery of therapeutic drugs.
实现和谐的肠道微生物生态系统被认为是缓解代谢紊乱的一种成功方法。施用益生菌,如[具体益生菌名称1]和[具体益生菌名称2],是调节人体共生微生物的一种已知的传统且安全的途径。随着基因测序和基因编辑工具的进步,越来越多的细菌能够作为具有多种治疗特性的工程益生菌发挥作用。作为下一代益生菌候选物之一,[具体细菌名称]([细菌拉丁学名])已被发现可增强肠道屏障功能并减轻炎症反应,经巴氏杀菌后效果更佳,且在肥胖、2型糖尿病、动脉粥样硬化和自闭症相关胃肠道紊乱患者中显示出有益的益生菌作用。鉴于此,本综述旨在总结[具体细菌名称]在治疗代谢紊乱方面的作用,并讨论几种用于[具体细菌名称]基因改造的成熟重组系统。通过深入了解其遗传背景,摄入的[具体细菌名称]有望用于各种应用,包括作为诊断工具以及治疗药物的位点特异性递送。